 Naltrexone functional hypothalamic amenorrhea normal luteal phase Fifteen young women diagnosis secondary hypothalamic amenorrhea years duration mg naltrexone daily placebo randomized double-blind crossover scheme Seven patients therapy following results mean SD range cycle length days naltrexone days placebo follicular phase length days naltrexone days naltrexone days placebo number ovulatory cycles naltrexone placebo luteal phases short women naltrexone placebo luteal phase crossover scheme Steroidogenesis normal luteal phase naltrexone therapy functional hypothalamic amenorrheic patients normal weight menstruation placebo naltrexone clinical therapeutic advantage ovulation rate